Antagonism of insulin and lipolytic hormones in the control of adenylate-cyclase activity in fat cells,.
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000273:Adipose Tissue / Q000378:metabolism*; D000324:Adrenocorticotropic Hormone / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D000818:Animals; D002458:Cell Fractionation; D000242:Cyclic AMP / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004789:Enzyme Activation; D004822:Epididymis; D005934:Glucagon / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D066298:In Vitro Techniques; D007328:Insulin / Q000494:pharmacology*; D008297:Male; D008854:Microscopy, Electron; D009638:Norepinephrine / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D051381:Rats; D014357:Trypsin
D007328:Insulin; D000324:Adrenocorticotropic Hormone; D005934:Glucagon; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases; D014357:Trypsin; D000262:Adenylyl Cyclases; D009638:Norepinephrine